Phase Genomics

About Phase Genomics

Phase Genomics is a life science innovation company focused on ultra-long-range genome sequencing technology. They aim to unlock novel insights in genomics, cytogenetics, oncology, and microbiology to address pressing health and environmental challenges, empowering scientists to transform genomic discovery and accelerate breakthroughs in research and medicine.

Products & Services

CytoTerra® Platform:A platform for advanced cytogenetic analysis to identify and characterize chromosomal abnormalities.

ProxiMeta™ Platform:A platform for metagenomics, aiding in deconvolution of complex samples and host attribution.

Proximo™ Platform:A platform for ultra-long-range sequencing to support high-quality genome assembly.

All Products & Services:Comprehensive solutions for genomic research and applications.

Specialties

Ultra-long-range genome sequencing Next-generation cytogenetics Precision oncology Metagenomics and microbiology Plant and animal genomics Computational bioinformatics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1500000 MR: - FA: $1.5MM FAN: 1500000	D: 2024-03-05 FD: 2024-03-05	1 investors

Grant Latest

2024-03-05

$1.5M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Ivan Liachko

Founder & CEO

K

Kayla Young

COO

S

Stephen Eacker

VP of Research & Development

J

Jay Shendure

Co-Founder & Scientific Advisor

M

Maitreya Dunham

Co-Founder & Scientific Advisor

E

Elhanan Borenstein

Scientific Advisor

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Phase Genomics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised